Dupilumab treatment in younger children with AD may improve lifelong growth outcomes

The impact of secukinumab on mental well-being in patients with moderate to severe HS: Post-hoc analysis of the SUNSHINE/SUNRISE trials

Baricitinib maintains safety profile over 4.6 years in final BREEZE-AD trials analysis

Digital health program reduces AD symptoms and scratching in real-world study

Home-based phototherapy as effective as in-office care for psoriasis: Results of the LITE study